Active, Not Recruiting
A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202
NCT06062420
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- GSK Investigational Site New Haven, Connecticut, United States
- GSK Investigational Site Iowa City, Iowa, United States
- GSK Investigational Site St Louis, Missouri, United States
- GSK Investigational Site Columbus, Ohio, United States